INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 462
17/06/2016
Projectes
Termini exhaurit
FJL - FONDATION JEROME LEJEUNE
The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
 
Termini exhaurit
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation.
 
Premis
Termini exhaurit
ASCI - American Society for Clinical Investigation
The American Society for Clinical Investigation (ASCI) established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.

The Harrington Discovery Institute at University Hospitals Case Medical Center, part of a national initiative unveiled in February 2012 called the Harrington Project, is a nonprofit medical institute dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. The Harrington Project is fueled by $250 million in donations and other funding, including $50 million from the Harrington Family.
 
Termini exhaurit
Escuela de Medicina de la Educación Física y del Deporte de la Universidad de Oviedo
La present convocatòria té per objecte la concessió dels Premis Liberbank de Recerca en Medicina de l'Esport, any 2015, patrocinats per la citada entitat financera, reconeixent públicament la labor realitzada per diferents investigadors i incentivar les iniciatives de recerca d'excel·lència en l'àmbit de la Medicina de l'Esport. Es premiarà un màxim de tres dels treballs presentats relacionats amb la Medicina de l'Esport.
 
Termini exhaurit
ANECORM - ASOCIACIÓN NACIONAL DE ENFERMERÍA COORDINADORA DE RECURSOS MATERIALES
Estimular la recerca entre els professionals d'infermeria, contribuir en el desenvolupament de la innovació científica, promoure la qualitat en el procés de recerca i aportar un benefici al sistema sanitari.
 
Recursos Humans
Termini exhaurit
HUMAN FRONTIER SCIENCE PROGRAMME

The Human Frontier Science Program Organization (HFSPO) supports innovative basic research into fundamental biological problems, with emphasis placed on novel approaches that cross disciplinary boundaries.

Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work.

Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have not worked in biological fields during their previous training.

The HFSP fellowship program funds innovative, ground-breaking projects that have the potential to advance knowledge in the applicants’ field of study or open a new approach to a research problem. High risk research is supported.
 
Termini exhaurit
CICS - ASOCIACIÓN CERVECEROS DE ESPAÑA
Concedir dues beques per a la realització de treballs de recerca experimental sobre el consum moderat de cervesa en relació amb la salut i la nutrició, que no s’hagin difós amb anterioritat a Espanya.
 
 
 
Informació últil
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
FEDER - FEDER
Fomentar el desenvolupament de la recerca en l'àmbit de les malalties poc freqüents mitjançant el finançament de projectes de recerca.
Tindran caràcter de recerques objecte d'aquesta convocatòria la recerca básica i translacional.
Es consideren malalties rares o poc freqüents aquelles que compleixen els paràmetres de prevalença reconeguts internacionalment, és a dir que compleixen dos criteris:
1) la prevalença acceptada per la Unió Europea de 5 o menys casos per 10.000 habitants, i
2) que la malaltia estigui inclosa en les bases de dades Orphanet (www.orpha.net) o OMIM (www.ncbi.nlm.nih.gov/omim) amb nombre ORPHA o OMIM assignat.
 
Termini exhaurit
BRAIN & BEHAVIOR RESEARCH FOUNDATION
The Brain & Behavior Research Foundation is the largest philanthropic organization dedicated to research across all brain and behavior disorders (not disease specific). Recipients of NARSAD Grants represent an extraordinary variety of disciplines. Research has included (but is not limited to) studies in: genetics, neurobiology, molecular biology, imaging, neurochemical studies, neurophysiology, electrophysiology, clinical psychopharmacology, descriptive clinical studies, epidemiological research, treatment modalities, cognition studies, and outcome and prevention research.
 
Termini exhaurit
DEMENTIA CONSORTIUM
The Dementia Consortium aims to expedite the development of new drugs for dementia by supporting research into novel targets for neurodegeneration. It brings together the voluntary, academic and private sectors in order to tackle the growing dementia problem. The Consortium seeks to end the ten-year wait for a new dementia treatment by closing the gap between fundamental academic research and the pharmaceutical industry’s drug discovery programmes. It provides funding, expertise and resources to support new drug targets emerging from academic research that hold the promise of patient benefit.
 
Termini exhaurit
MINECO - MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD
Amb el finançament de les Xarxes d'Excel·lència es pretén que els grups participants en aquestes xarxes puguin tant planificar activitats conjuntes futures com consolidar resultats d'activitats de R+D+I anteriors, incloent aquelles desenvolupades en el marc dels Campus d'Excel·lència Internacional. També es pretén oferir suport a les activitats de promoció internacional i posicionament estratègic, mitjançant l'optimització de resultats i recursos, amb la vocació de situar la recerca espanyola, com a eix fonamental de desenvolupament econòmic i social, en l'avantguarda de la ciència i la tecnologia, tant a nivell nacional com internacional. La finalitat d'aquestes accions de dinamització és impulsar la internacionalització de les activitats de R+D i contribuir a l'avanç del coneixement per afrontar els desafiaments que la recerca espanyola té en el context de l'Espai Europeu de Recerca.
 
Termini exhaurit
RecerCaixa 2017
La convocatòria d’ajuts a la recerca RecerCaixa finançarà projectes de recerca desenvolupats per investigadors i investigadores de les universitats i centres de recerca de Catalunya.
La convocatòria persegueix principalment dos objectius: impulsar la recerca científica d'excel·lència al nostre país i acostar la ciència a la societat, fent-la partícip dels avenços científics i dels beneficis humans i socials.
 
Termini exhaurit
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
Career Catalyst (CCR) Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant, thereby playing key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
 
Termini exhaurit
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
Career Catalyst (CCR) Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of “protected time” for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant, thereby playing key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
 
Termini exhaurit
ROI - RADIATION ONCOLOGY INSTITUTE
The ROI is currently seeking research proposals for innovative approaches to making quality assurance (QA) more personalized by using big data to identify patient, disease or treatment characteristics that are predictive of unwanted outcomes, dosimetric uncertainties or outright errors, needed patient management interventions or general process variability. The goal is to get researchers thinking about how QA efforts can be differentiated by the level of risk for each patient so that resources can be allocated accordingly, in comparison to the current QA model in which “one size fits most.”
 
Termini exhaurit
FUNDACIO LA CAIXA
L'objecte de la present convocatòria és la tutoria de projectes de valorització dels actius resultants de la investigació, per al seu trasllat al mercat, ja sigui com un spin-off o com un acord de transferència, que requereixen la validació i desenvolupament de la seva proposta de generació de valor.
Més específicament, el programa donarà suport a projectes de les àrees de la Vida, Medicina i Ciències de la Salut proposades pels centres, basats en actius per als quals s'ha sol·licitat o serà sol·licitada una patent o model d'utilitat, i destinats a afegir valor per a la seva transferència al mercat.
Dins les àrees de la Vida, Medicina i Ciències de la Salut, es tindran en compte els projectes dels següents camps:
  • Ciències de la Vida: Biomatemàtica, Biologia Cel·lular, Biologia Humana, Bioquímica i Biologia Molecular, Fisiologia Humana, Genètica, Immunologia, Microbiologia i Neurociències.
  • Ciències Mèdiques i de la Salut: Ciències Clíniques, Epidemiologia, Medicina Forense, Medicina del treball, Medicina Interna, Ciències de la nutrició, Patologia, Farmacodinàmica, Farmacologia, Medicina Preventiva, Psiquiatria, Salut Pública, Cirurgia i Toxicologia.
  •  
    Termini exhaurit
    FRIEDREICH'S ATAXIA RESEARCH ALLIANCE
    FARA supports research through funding competitive grants, promoting collaboration among scientists, advocating for public-private partnerships that support drug discovery, drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA.
     
    Altres
    Termini exhaurit
    AGAUR - AGENCIA DE GESTIO AJUTS UNIVERSITARIS DE RECERCA
    Atorgar ajuts per a tesis doctorals en català que s'hagin defensat durant el 2015, destinats a contribuir a les despeses i les taxes administratives associades amb la finalització de la tesi doctoral i amb el tràmit d'obtenció del títol de doctor o doctora.
     
    Borses de viatge
    Termini exhaurit
    UICC-GLOBAL CANCER CONTROL
    Union for International Cancer Control (UICC) is a membership organisation that exists to help the global health community accelerate the fight against cancer.
    Founded in 1933 and based in Geneva, UICC’s growing membership of over 900 organisations across 155 countries, features the world’s major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, World Economic Forum and others, UICC is tackling the growing cancer crisis on a global scale.
     
    Recursos Humans
    Termini exhaurit
    FUNDACIÓN TATIANA PÉREZ DE GUZMÁN EL BUENO
    Convocar 5 beques/contractes predoctorals en Neurociència per a espanyols que vagin a realitzar la seva tesi doctoral en un Programa de doctorat acreditat oficialment a Espanya.
    L'objectiu de les beques/contractes és la realització de la tesis doctoral en Neurociència enfocada a la comprensió del sistema nerviós humà i de les malalties que l'afecten.
     
    Termini exhaurit
    BAYER
    Bayer's mission is to provide new treatment options for diseases with high unmet medical need.
    The Bayer Fellowship Program targets students and apprentices in scientific and medical disciplines. Its goal is to support the next generation of researchers and teachers as they engage in “Science for a Better Life”.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Postdoctoral Fellowship (PDF) Grants are intended to attract and support promising scientists and clinician/scientists who are embarking on careers dedicated to breast cancer research. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within in the next decade, with the ultimate goal of ending breast cancer forever.
     
    Termini exhaurit
    THE SUSAN G. KOMEN BREAST CANCER FOUNDATION
    Postdoctoral Fellowship (PDF) Grants are intended to attract and support promising scientists and clinician/scientists who are embarking on careers dedicated to breast cancer research. By providing funding to outstanding postdoctoral/postgraduate fellows under the guidance of a mentor, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within in the next decade, with the ultimate goal of ending breast cancer forever.
     
     
     
     
    Articles
     
    Espinosa L*. Endosomal acidification inhibitors for the treatment of BRAF mutant tumors. Mol Cell Oncol 2016; 3(2): e1062073.
     
    Krishnan A*, Woo CW, Chang LJ, Ruzic L, Gu X, López-Solà M, Jackson PL, Pujol J, Fan J, Wager TD*. Somatic and vicarious pain are represented by dissociable multivariate brain patterns. eLife 2016; 5: e15166.
     
     
    Downer MK, Gea A, Stampfer M, Sánchez-Tainta A, Corella D, Salas-Salvadó J, Ros E, Estruch R, Fitó M, Gómez-Gracia E, Arós F, Fiol M, García de la Corte FJ, Serra-Majem L, Pintó X, Basora J, Sorli JV, Vinyoles E, Zazpe I, Martínez-González MA*. Predictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial. Int J Behav Nutr Phys Act 2016; 13: 67.
     
    Mullane SA, Werner L, Rosenberg J, Signoretti S, Callea M, Choueiri TK, Freeman GJ, Bellmunt J*. Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma. Sci Rep 2016; 6: 27702.
     
    Vargas-Prada S, Demou E, Lalloo D, Avila-Palencia I, Sanati KA, Sampere M, Freer K, Serra C*, Macdonald EB. Effectiveness of very early workplace interventions to reduce sickness absence: a systematic review of the literature and meta-analysis. Scand J Work Environ Health 2016; 42(4): 261-272.
     
    Giménez-Arnau AM*, Toubi E, Marsland AM, Maurer M. Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2016; 30(Suppl 5): 25-32.
     
    Maurer M, Giménez-Arnau AM*, Zuberbier T. What is new and upcoming in the world of chronic urticaria?. J Eur Acad Dermatol Venereol 2016; 30(Suppl 5): 5-6.
     
    García-Gil M, Parramon D, Comas-Cufí M, Martí R, Ponjoan A, Alves L, Blanch J, Petersen I, Elosua R, Grau M, Salvador B, Ramos R*. Role of renal function in cardiovascular risk assessment: A retrospective cohort study in a population with low incidence of coronary heart disease. Prev Med 2016; 89: 200-206.
     
    Hinarejos P*, Capurro B, Santiveri X, Ortíz P, Leal J, Pelfort X, Torres R, Sánchez-Soler JF, Monllau JC. Local infiltration analgesia adds no clinical benefit in pain control to peripheral nerve blocks after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2016; 24(10): 3299-3305.
     
    de la Torre R, de Sola S, Hernández G, Farré M, Pujol J, Rodríguez J, Espadaler JM, Langohr K, Cuenca A, Principe A, Xicota L, Janel N, Catuara S, Sánchez-Benavides G, Blehaut H, Dueñas I, del Hoyo L, Benejam B, Blanco-Hinojo L, Videla S, Fitó M, Delabar JM, Dierssen M*, TESDAD study group. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurology 2016; 15(8): 801-810.
     
    Blain H*, Masud T, Dargent-Molina P, Martin FC, Rosendahl E, van der Velde N, Bousquet J, Benetos A, Cooper C, Kanis JA, Reginster JY, Rizzoli R, Cortet B, Barbagallo M, Dreinhöfer KE, Vellas B, Maggi S, Strandberg T, The EUGMS Falls and Fracture Interest Group, The International Association of Gerontology and Geriatrics for the European Region (IAGG-ER), The European Union of Medical Specialists (EUMS) The Fragility Fracture Network (FFN), The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), and the International Osteoporosis Foundation (IOF) (...,Díez-Pérez A,...). A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement. J Nutr Health Aging 2016; 20(6): 647-652.
     
    Poglayen D, Marín-López MA, Bonet J, Fornes O, García-García J, Planas-Iglesias J, Segura J, Oliva B*, Fernandez-Fuentes N*. InteractoMIX: a suite of computational tools to exploit interactomes in biological and clinical research. Biochem Soc T 2016; 44(3): 917-924.
     
     
    Estruch R*, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Chiva-Blanch G, Fiol M, Gómez-Gracia E, Arós F, Lapetra J, Serra-Majem L, Pintó X, Buil-Cosiales P, Sorli JV, Muñoz MA, Basora-Gallisá J, Lamuela-Raventós RM, Serra-Mir M, Ros E, PREDIMED Study Investigators. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol 2016; 4(8): 666-676.
     
    Robles EF, Mena-Varas M, Barrio L, Merino-Cortes SV, Balogh P, Du MQ, Akasaka T, Parker A, Roa S, Panizo C, Martin-Guerrero I, Siebert R, Segura V, Agirre X, Macri-Pellizeri L, Aldaz B, Vilas-Zornoza A, Zhang S, Moody S, Calasanz MJ, Tousseyn T, Broccardo C, Brousset P, Campos-Sanchez E, Cobaleda C, Sánchez-García I, Fernandez-Luna JL, Garcia-Muñoz R, Peña E, Bellosillo B, Salar A, Baptista MJ, Hernández-Rivas JM, González M, Terol MJ, Climent J, Ferrández A, Sagaert X, Melnick AM, Prosper F, Oscier DG, Carrasco YR, Dyer MJ, Martínez-Climent JA*. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics. Nat Commun 2016; 7: 11889.
     
    Lana F, Sánchez-Gil C, Pérez V, Martí J. A stepped care approach to psychotherapy in borderline personality disorder. Ann Clin Psychiatry 2016; 28(2): 140-141.
     
    Socias L*, Frontera G, Rubert C, Carrillo A, Peral V, Rodríguez A, Royo C, Ferreruela M, Torres J, Elosua R, Bethencourt A, Fiol M, en representación del Grupo de Investigadores del CI-IB y del IBERICA. Análisis comparativo de 2 registros de infarto agudo de miocardio tras una década de cambios. Estudio IBERICA (1996-1998) y Código Infarto-Illes Balears (2008-2010). Medicina Intensiva 2016; 40(9): 541-549.
     
    Burón A*, Posso M, Sivilla J, Grau J, Guayta R, Castells X, Castells A, Macià F, en nombre del Grupo Procolon. Análisis de la satisfacción de los participantes en el Programa de detección precoz de cáncer colorrectal de Barcelona: valoración positiva de la farmacia comunitaria. Gastroenterol Hepatol 2017; 40(4): 265-275.
     
    Downey C*, Requena L, Bagué S, Sánchez-Martínez MA, Lloreta J, Baselga E. Agminated Fibroblastic Conective Tissue Nevus: A New Clinical Presentation. Pediatr Dermatol 2016; 33(4): e240-e243.
     
     
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).